Skip to main content

Table 2 Tumor response at 1 month between DEB-TACE and cTACE

From: Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients

Tumor response

DEB-TACE (N = 24)

cTACE (N = 32)

p-value

Tumor response (all)

 CR

5

2

0.125

 PR

12

9

0.094

 SD

5

13

0.117

 PD

2

8

0.162

 ORR

17

11

0.007*

Necrosis rate (ORR)

 30–50%

4

7

0.053

 ≥ 50%

13

4

  1. *p < 0.05